The FDA cleared a mobile medical application to increase retention in an outpatient treatment program for individuals with opioid use disorder (OUD).
The reSET-O app (Sandoz/Pear Therapeutics) is a prescription cognitive-behavioral therapy intended to be used in addition to outpatient treatment under the care of a health professional, in conjunction with treatment that includes buprenorphine and contingency management. Contingency management is a behavior modification intervention that